Esculentoside C
CAS No. 65931-92-2
Esculentoside C( —— )
Catalog No. M30913 CAS No. 65931-92-2
Esculentoside C exerts proinflammatory effects synergistically, it can induce inflammatory stimulation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 567 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEsculentoside C
-
NoteResearch use only, not for human use.
-
Brief DescriptionEsculentoside C exerts proinflammatory effects synergistically, it can induce inflammatory stimulation.
-
DescriptionEsculentoside C exerts proinflammatory effects synergistically, it can induce inflammatory stimulation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65931-92-2
-
Formula Weight810.97
-
Molecular FormulaC42H66O15
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SARS-CoV-2 Mpro-IN-9
SARS-CoV-2 Mpro-IN-9 (compound c7), a nonpeptidic, noncovalent inhibitor of SARS-CoV-2 main protease (Mpro), exhibits potent inhibitory action (IC50 = 0.085 μM) and improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties.
-
SBI993
SBI993 is an analog of SBI-477 and can be used as a biomarker to confirm the expected action of MondoA target gene expression in vivo. SBI993 reduces muscle TAG levels and hepatic steatosis.
-
Emorfazone
Emorfazone has an anti-nociceptive effect.
Cart
sales@molnova.com